-> DO NOT EDIT OR MOVE THIS ELEMENT <-

Cancer Tests

Starting from our powerful AI Platform we managed to develop a powerful diagnosis service.

-> DO NOT EDIT OR MOVE THIS ELEMENT <-

Artificial Intelligence - multi cancer detection Test

AI-MCDT

AI-MCDT (patent pending) is based on advanced Artificial Intelligence (Machine Learning and Deep Learning algorithms) and uses circulating miRNA microarray, NGS or PCR data as input for multi-cancer diagnosis and early detection diagnosis. It is the best non-invasive early-detection test on the market with >99% accuracy for thirteen cancers types, thus increasing treatment efficiency, patient survival rate and lowering costs.

Cancer Tests

Find out about our multi cancer test (AI-MCDT) and our multiple AI applications.

VIEW DETAILS >

-> DO NOT EDIT OR MOVE THIS ELEMENT <-

Research

Discover more details about the projects that we take part in.

VIEW DETAILS >

Services

Omics data analysis services with AI.

VIEW DETAILS >

-> DO NOT EDIT OR MOVE THIS ELEMENT <-

Health and Medicine

The AI Multi Cancer Test

Patent Pending

Our groundbreaking solution enables early diagnosis and screening for 13 types of cancers, with > 99% accuracy, being the best. The test increases treatment efficiency, patient survival rate, and lowers the costs. It is based on a radically new vision, combining Biomedical Knowledge, Data Science, and advanced AI. It only needs a drop of blood, avoiding the fear, pain, and risks related to the surgical procedures, actually dominating the cancer diagnosis practice.

-> DO NOT EDIT OR MOVE THIS ELEMENT <-

mACHINE LEARNING AND dEEP lEARNING

The AI Platform

While our main interest is to validate the cancer tests, we’re also developing a continuously evolving AI platform for omics data analysis. Using various grants, we are planning to add modules for toxicogenomics, microbiomics and pharmacogenomics.